Editorial issue 303

The first 3 papers selected for this 303rd issue of NDT-E deal with various aspects of glomerular diseases. SJ Barbour first recently published in Kidney Int that "The MEST score provides earlier risk prediction in IgA nephropathy". Next, M Rathi M et al, again in Kidney Int report a "Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis." And S Lovric  et al address in a recent NDT paper another important complex issue “Genetic testing in steroid-resistant nephrotic syndrome: when and how?"
In the fourth paper, Maruyama A et al provide an update in NDT on a rapidly moving field "A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney disease2. Eventually, CKD/dialysis patients may be cured tool from chronic HCV, an exciting development. Finally, TO Van den Beukel et al report an interesting registry study showing "Differences in survival on chronic dialysis treatment between ethnic groups in Denmark: a population-wide, national cohort study".

CME lectures   
The 2 CME lectures presented in London at ERA-EDTA last may deal with inflammatory conditions affecting the kidney. Dr Helen Lachmann (London, UK) reviews "What do nephrologists need to know about the auto-inflammatory disorders?". And Dr Justin Mason (London, UK) provides an overview on "Takayasu arteritis and the kidney".

Enjoy NDT-Edu!

Prof. Michel Jadoul
Editor-in-Chief NDT-Educational